Literature DB >> 6407156

Application of the leucocyte adherence inhibition test to the assessment of cell mediated immunity in invasive amoebiasis.

T F Jackson, J Duursma, A E Simjee, D J Pudifin.   

Abstract

The leucocyte adherence inhibition (LAI) test was assessed as a means for measuring specific cell mediated immunity (CMI) in invasive amoebiasis. The LAI test and the amoebic gel diffusion (AGD) test were performed on 20 patients admitted to hospital with amoebic liver abscess (ALA) and 24 control subjects with no demonstrable clinical amoebiasis. The AGD results were acceptable for such a study in an endemic area as all the proven ALA subjects gave positive responses while all except one of the controls gave a negative reaction. A percentage adherence in the LAI test of more than 80% was considered to be negative and the mean percentage adherence of leucocytes for the control subjects was found to be 86.0 +/- 4.9 while that for the experimental group was found to be 76.1 +/- 15.4; the difference between these groups is statistically significant. It was noticed that the LAI test response was possibly linked with severity of disease in the ALA subjects. The LAI test has been found to be a relatively rapid test of specific CMI and although fastidious, it does not require the use of radio-isotopes.

Entities:  

Mesh:

Year:  1983        PMID: 6407156     DOI: 10.1016/0035-9203(83)90036-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  2 in total

1.  Detection of Entamoeba histolytica immunoglobulins G and M to plasma membrane antigen by enzyme-linked immunosorbent assay.

Authors:  M A Sathar; B L Bredenkamp; V Gathiram; A E Simjee; T F Jackson
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody.

Authors:  D J Pudifin; J Duursma; V Gathiram; T F Jackson
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.